Raynaud's Syndrome Terminated Phase 2 / 3 Trials for Bupivacaine (DB00297)

Also known as: Raynaud’s phenomenon / Raynaud's Phenomenon / Raynaud’s syndrome / Raynaud Syndrome / Raynaud / Raynaud's Disease / Raynaud phenomenon / Raynauds / Raynaud's syndrome NOS / Raynauds' phen / Raynaud Disease

IndicationStatusPhase
DBCOND0049133 (Raynaud's Syndrome)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02374320Exparel as a Nerve Block for Severe Hand PainTreatment